Left Ventricular Thrombus Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-17

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Left Ventricular Thrombus (LVT) is a blood clot that can develop in a poorly functioning heart. In around 1 in 6 patients who have had a heart attack or diagnosed with heart failure tend to develop blood clots in their main heart chamber.

Having a blot clot in the main heart chamber can lead to serious complications such as stroke. Treatment for blood clots is blood thinning medications, which if taken for a prolonged period of time can result in bleeding which further complicates treatment. We hope to gather information to better understand the factors associated with blood clot formation and management in the lower left chamber of the heart. This understanding will hopefully enable us and others to improve management of this condition in the future and therefore help the wider population. As part of this study, bloods and scan results will be recorded and we will complete a short quality of life questionnaire. When participants come in for routine MRI scan, we may capture additional images for further research analysis.

A sample of blood no more than one tablespoon will be collected for research analysis at the same time as routine blood test. This will occur at baseline and at around 6 months. At 12 months we will repeat the quality of life questionnaire and collect final data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Left Ventricular Pacing to Avoid Cardiac Enlargement Study

NCT01302717

Complete AV Block Sick Sinus Syndrome

WITHDRAWN NA

Influence of Cardiac Implantable Electronic Devices on the Hemostatic System

NCT04499612

Thromboembolism Cardiac Event Hemostatic Disorder

COMPLETED

Left vs Left Randomized Clinical Trial

NCT05650658

Heart Failure Heart Failure With Reduced Ejection Fraction AV Block +4 more

RECRUITING NA

Predictors of Risk in Left Ventricular Non-Compaction

NCT06024759

Left Ventricular Noncompaction

RECRUITING

Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study

NCT02314897

Tricuspid Valve Insufficiency Sick Sinus Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Left Ventricular Thrombus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LV Thrombus (present)

Patients with a diagnosis of LV thrombus in the setting of LV dysfunction (acute myocardial infarction, Ischaemic Cardiomyopathy (ICM), dilated cardiomyopathy (DCM)).

No interventions assigned to this group

LV Thrombus (at risk)

Patients that do not have LV thrombus but are at risk for developing thrombus such as those with severe LV dysfunction, LV aneurysms, large territory infarcts will also be included.

No interventions assigned to this group